Retinol and endometriosis - is everything simple in pathogenesis?

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. External genital endometriosis (EGE) is a chronic, relapsing, progressive, hormone-dependent disease characterized by a benign growth of tissue outside the uterine cavity, similar in morphological structure and functions to the endometrium. The versatility of the pathogenetic mechanisms of the development of the disease, the variability of clinical symptoms, as well as the lack of a unified concept of endometriosis therapy dictate the need to find modern methods for correcting this pathology. Retinol may be one of these areas.

Objective. Determination of the retinol level of in peripheral blood and peritoneal fluid in patients with EGE, evaluation of the effectiveness of its use on the basis of surgically induced endometriosis in Wistar rats.

Methods. The main group included 38 patients with a histologically confirmed (based on laparoscopy) diagnosis of I-IV stage EGE according to the revised classification of the American Society for Reproductive Medicine (r-ASRM); mean age of patients was 31.7±4.1 years. The control group consisted of 10 patients without endometriosis who underwent diagnostic laparoscopy before entering the protocol of assisted reproductive technologies. Determination of the blood serum and peritoneal fluid vitamin A level in was carried out using Cloud-Clone Corp kits by ELISA.

Experimental model. A surgically induced model of endometriosis was performed on 21 mature female Wistar rats. The creation of the experimental model was carried out in three stages. The first stage was the modeling of the disease, the second was the confirmation of the presence of endometriosis based on laparoscopy and the assessment of the area of endometrioid heterotopias, followed by drug therapy of the disease; the third stage was the removal of animals from the experiment, the assessment of the area of endometrioid heterotopias in dynamics, and histological examination.

Results and discussion. Based on our study, it was found that patients with endometriosis have an increased blood serum vitamin A level, which significantly exceeds its level in the peritoneal fluid by 2 times, especially in the initial forms of the disease. An «artificial» increase in the level of retinol in the blood serum can be mediated by many reasons, primarily by disorders of its metabolism and changes in the retinol-binding protein 4 expression, that justifies the need for further research to study in depth the role of vitamin A in the pathogenesis of endometriosis. At the same time, the high efficiency of the use of retinol, characterized by complete resorption of endometriosis foci based on an experimental model of a surgically induced disease in Wistar rats, makes it possible to consider retinol as a promising method of treating the disease.

Full Text

Restricted Access

About the authors

Maria I. Yarmolinskaya

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Author for correspondence.
Email: m.yarmolinskaya@gmail.com
ORCID iD: 0000-0002-6551-4147

Dr. Sci. (Med.), Professor, Professor of the Russian Academy of Sciences, Head of the Department of Gynecology and Endocrinology, Head of the Center for Diagnostics and Treatment of Endometriosis; Professor of the Department of Obstetrics and Gynecology

Russian Federation, St. Petersburg

Ch. I. Seyidova

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: m.yarmolinskaya@gmail.com
ORCID iD: 0000-0002-6800-8661
Russian Federation, St. Petersburg

N. N. Tkachenko

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: m.yarmolinskaya@gmail.com
ORCID iD: 0000-0001-6189-3488
Russian Federation, St. Petersburg

T. G. Tral

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: m.yarmolinskaya@gmail.com
ORCID iD: 0000-0001-8948-4811
Russian Federation, St. Petersburg

References

  1. Denisova A.S., Yarmolinskaya M.I., Tkachenko N.N. Status of 25(OH)D in patients with external genital endometriosis and clinical efficacy of colecalciferol in the treatment of the disease. Zhurnal akusherstva i zhenskikh boleznei. 2021;70(4):125–33. (In Russ.). Doi: 10.17816/ JOWD62883.
  2. Becker C.M., Bokor A., Heikinheimo O., et al. ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2): hoac009. doi: 10.1093/hropen/hoac009.
  3. Zondervan K.T., Becker C.M., Missmer S.A. Endometriosis. N Engl J Med. 2020;382(13):1244–56. doi: 10.1056/NEJMra 1810764.
  4. Yarmolinskaya M.I., Beganova A.K., Revenko A.S. Endometriosis-associated pain syndrome and new possibilities of therapy. Ginekologiya. 2022;24(6):444–50. (In Russ.). doi: 10.26442/20795696.2022. 6.201975.
  5. Pierzchalski K., Taylor R.N., Nezhat C., et al. Retinoic acid biosynthesis is impaired in human and murine endometriosis. Biol. Reprod. 2014;91(4):84. doi: 10.1095/biolreprod.114.119677.
  6. Seiidova Ch.I., Yarmolinskaya M.I. Vitamin A and pregnancy - myths and reality, prospects for use in endometriosis (literature review). Zhurnal akusherstva i zhenskikh boleznei. 2021;70(6):139–46. (In Russ.). doi: 10.17816/JOWD72297.
  7. Zinder R., Cooley R., Vlad L.G. et al. Vitamin A and wound healing. Nutr Clin Pract. 2019;34(6):839–49. doi: 10.1002/ncp.10420.
  8. D’Ambrosio D.N., Clugston R.D., Blaner W.S. Vitamin A metabolism: an update. Nutrients. 2011;3(1):63–103. doi: 10.3390/nu3010063.
  9. Stevison F., Jing J., Tripathy S., et al. Role of retinoic acid- metabolizing cytochrome P450s, CYP26, in inflammation and cancer. Adv Pharmacol. 2015;74:373–412. doi: 10.1016/bs.apha.2015.04.006.
  10. Li Y., Wang L, Ai W., et al. Regulation of retinoic acid synthetic enzymes by WT1 and HDAC inhibitors in 293 cells. Int J Mol Med. 2017;40(3):661–72. doi: 10.3892/ijmm.2017.3051.
  11. Yamagata Y., Nishino K., Takaki E., et al. Genome-wide DNA methylation profiling in cultured eutopic and ectopic endometrial stromal cells. PLoS One. 2014;9. doi: 10.1371/journal.pone.0083612.
  12. Yamagata Y., Takaki E., Shinagawa M., et al. Retinoic acid has the potential to suppress endometriosis development. J Ovarian Res. 2015;8:49. doi: 10.1186/s13048- 015-0179-6.
  13. Parazzini F., Viganò P., Candiani M., et al. Diet and endometriosis risk: a literature review. Reprod BioMed Online. 2013;26(4):323–36. doi: 10.1016/j.rbmo.2012.12.011.
  14. Mier-Cabrera J., Aburto-Soto T., Burrola-Mendez S., et al. Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet. Reprod Biol Endocrinol. 2009;7:54. doi: 10.1186/1477-7827-7-54.
  15. Van Landendonckt A., Casanas-Roux F., Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril. 2002; 77:861–70. doi: 10.1016/S0015-0282(02)02959-X.
  16. Huang Q.-T., Huang Q., Luo W., et al. Circulating retinol-binding protein 4 levels in gestational diabetes mellitus: A meta-analysis of observational studies. Gynecol Endocrinol. 2015;31:337–44. doi: 10.3109/09513590.2015.1005594.
  17. Lee J.C., Kim S.H., Oh Y.S., et al. Increased Expression of Retinol-Binding Protein 4 in Ovarian Endometrioma and Its Possible Role in the Pathogenesis of Endometriosis. Int J Mol Sci. 2021;22(11):5827. doi: 10.3390/ijms22115827.
  18. Karunanithi S., Levi L., DeVecchio J. et al. RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis. Stem Cell Rep. 2017;9:438–50. doi: 10.1016/j.stemcr.2017.06.002.
  19. Cheng Y., Liu C., Zhang N. et al. Proteomics Analysis for Finding Serum Markers of Ovarian Cancer. BioMed Res. Int. 2014;2014:1–9. doi: 10.1155/2014/179040.
  20. Al Tanoury Z., Piskunov A., Rochette- Egly C. Vitamin A and retinoid signaling: genomic and nongenomic effects. J Lipid Res 2013;54(7):1761–75. doi: 10.1194/jlr. R030833.
  21. Mrass P., Rendl M., Mildner M., et al. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis. Cancer Res. 2004;64(18):6542–48. doi: 10.1158/0008-5472.CAN-04-1129.
  22. Zhang H., Rosdahl I. Expression profiles of p53, p21, bax and bcl-2 proteins in all- trans-retinoic acid treated primary and metastatic melanoma cells. Int J Oncol. 2004;25(2):303–8.
  23. Di Masi A., Leboffe L., de Marinis E., et al. Retinoic acid receptors: from molecular mechanisms to cancer therapy. Mol Aspects Med. 2015;41:1–115. doi: 10.1016/j.mam.2014.12.003.
  24. Orywal K., Jelski W., Zdrodowski M., et al. The activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in ovarian cancer and ovarian cysts. Adv Med Sci. 2013;58(2):216–20. doi: 10.2478/ams-2013-0012.
  25. Wei J.J., William J., Bulun S. Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects. Int J Gynecol Pathol. 2011;30(6):553–68. doi: 10.1097/PGP.0b013e31821f4b85.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig.1. Endometrioid heterotopia before retinol therapy (during laparoscopy)

Download (51KB)
3. Fig.2. Endometrioid heterotopia in animals of the control group (at the stage of withdrawal from the experiment)

Download (91KB)
4. Fig.3. Connective tissue scar at the site of the implanted uterus in the group of animals treated with retinol. G-E, x100

Download (170KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies